Literature DB >> 22966084

HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Liusong Yin1, J Mauricio Calvo-Calle, Omar Dominguez-Amorocho, Lawrence J Stern.   

Abstract

HLA-DM (DM) is a nonclassical MHC class II (MHC II) protein that acts as a peptide editor to mediate the exchange of peptides loaded onto MHC II during Ag presentation. Although the ability of DM to promote peptide exchange in vitro and in vivo is well established, the role of DM in epitope selection is still unclear, especially in human response to infectious disease. In this study, we addressed this question in the context of the human CD4 T cell response to vaccinia virus. We measured the IC(50), intrinsic dissociation t(1/2), and DM-mediated dissociation t(1/2) for a large set of peptides derived from the major core protein A10L and other known vaccinia epitopes bound to HLA-DR1 and compared these properties to the presence and magnitude of peptide-specific CD4(+) T cell responses. We found that MHC II-peptide complex kinetic stability in the presence of DM distinguishes T cell epitopes from nonrecognized peptides in A10L peptides and also in a set of predicted tight binders from the entire vaccinia genome. Taken together, these analyses demonstrate that DM-mediated dissociation t(1/2) is a strong and independent factor governing peptide immunogenicity by favoring the presentation of peptides with greater kinetic stability in the presence of DM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22966084      PMCID: PMC3466378          DOI: 10.4049/jimmunol.1200626

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  68 in total

1.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro.

Authors:  M Frayser; A K Sato; L Xu; L J Stern
Journal:  Protein Expr Purif       Date:  1999-02       Impact factor: 1.650

2.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.

Authors:  P A Muraro; M Vergelli; M Kalbus; D E Banks; J W Nagle; L R Tranquill; G T Nepom; W E Biddison; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 4.  The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.

Authors:  Monika-Sarah E D Schulze; Kai W Wucherpfennig
Journal:  Curr Opin Immunol       Date:  2011-12-02       Impact factor: 7.486

5.  Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis.

Authors:  V Pinet; B Combe; O Avinens; S Caillat-Zucman; J Sany; J Clot; J F Eliaou
Journal:  Arthritis Rheum       Date:  1997-05

6.  Structure of a TCR with high affinity for self-antigen reveals basis for escape from negative selection.

Authors:  Yiyuan Yin; Yili Li; Melissa C Kerzic; Roland Martin; Roy A Mariuzza
Journal:  EMBO J       Date:  2011-02-04       Impact factor: 11.598

7.  Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein.

Authors:  C J Harrington; A Paez; T Hunkapiller; V Mannikko; T Brabb; M Ahearn; C Beeson; J Goverman
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

8.  Peptide binding predictions for HLA DR, DP and DQ molecules.

Authors:  Peng Wang; John Sidney; Yohan Kim; Alessandro Sette; Ole Lund; Morten Nielsen; Bjoern Peters
Journal:  BMC Bioinformatics       Date:  2010-11-22       Impact factor: 3.169

9.  T cells compete for access to antigen-bearing antigen-presenting cells.

Authors:  R M Kedl; W A Rees; D A Hildeman; B Schaefer; T Mitchell; J Kappler; P Marrack
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  DM determines the cryptic and immunodominant fate of T cell epitopes.

Authors:  N K Nanda; A J Sant
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

View more
  34 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.

Authors:  Crystal C Walline; Sarah N Deffit; Nan Wang; Lynette M Guindon; Victoria L Crotzer; Jianyun Liu; Kristin Hollister; Laurence C Eisenlohr; Randy R Brutkiewicz; Mark H Kaplan; Janice S Blum
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

3.  Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.

Authors:  Lance M Hellman; Liusong Yin; Yuan Wang; Sydney J Blevins; Timothy P Riley; Orrin S Belden; Timothy T Spear; Michael I Nishimura; Lawrence J Stern; Brian M Baker
Journal:  J Immunol Methods       Date:  2016-02-18       Impact factor: 2.303

Review 4.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

5.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

6.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

Review 7.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

Review 10.  Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Curr Protoc Immunol       Date:  2014-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.